API

GABAPENTIN is an anticonvulsant medication primarily used to treat partial seizures and neuropathic pain.It is a first-line medication for the treatment of neuropathic pain caused by diabetic neuropathy, postherpetic neuralgia, and central pain.

Products still subject to third-party patent protection might be available solely for R&D purposes.

FAVIPIRAVIR is an antiviral medication used to treat influenza in Japan. It is also being studied to treat a number of other viral infections, including SARS-CoV-2.

Products still subject to third-party patent protection might be available solely for R&D purposes.

MIRABEGRON, sold under the brand name Myrbetriq among others, is a medication used to treat overactive bladder. Its benefits are similar to antimuscarinic medication.

Products still subject to third-party patent protection might be available solely for R&D purposes.

EDOXABAN TOSYLATE is an anticoagulant medication and a direct factor Xa inhibitor.

Products still subject to third-party patent protection might be available solely for R&D purposes.